Scrutica
Compute
Power
GPUs
H100 Equiv
Supply Chain
Not yet available
Power capacity, hardware inventory, upstream suppliers, and downstream customers for the row owned by Recursion Pharmaceuticals; any BIS Entity List exposure is walked through the canonical org graph rather than asserted at the facility row.
Capacity, ownership chain, and supply-chain position for Recursion BioHive-2, including any export-control exposure that surfaces when the BIS Entity List touches a node above the facility in the chain.
As of 2026-06-12
Operator (or owner of record) per the Scrutica facility row.
Chain terminates at a publicly-listed entity (Recursion Pharmaceuticals). Subsequent ownership is observable via SEC filings or the equivalent national registry.
Timeline
Operational
May 13, 2024
Notes
Other Recursion Pharmaceuticals Facilities
No jurisdictions documented for this chain in the available data — at least one ancestor must carry an HQ country in the canonical organization record for jurisdictional exposure to compute. This section will populate automatically as additional ingestion adds HQ countries to the chain.
No flags found across the chain (BIS Entity List, designation-cascade closures, or compute-threshold reporting obligations) as of 2026-06-12. Cascade closures evaluated: 0.
No ownership-change events documented in the available data for any entity in this chain over the last 5 years. Events draw from a licensed corporate-ownership database’s deal records (M&A, buyout, divestiture, asset sale, JV formation); coverage is strongest for private US/EU transactions and partial for state-owned-enterprise restructurings or non-Western private deals. Subsequent ingestion runs may add events here.
Mubadala Investment Company
Mubadala is associated with United Arab Emirates’s UAE: Stargate UAE / G42 / Core42 / TII Sovereign AI + Microsoft Cumulative + Abu Dhabi Digital Strategy. See actor profile →
Touches Recursion Pharmaceuticals (chain hop 1) via a private-market fund. Commitment dollar value not disclosed (2021-08-17).
Saudi Arabia's Public Investment Fund
PIF is associated with Saudi Arabia’s Saudi Arabia: HUMAIN / Project Transcendence. See actor profile →
Touches Recursion Pharmaceuticals (chain hop 1) via a private-market fund. Commitment dollar value not disclosed (2019-12-31).
Qatar Investment Authority
QIA is a QA-domiciled sovereign vehicle (no Scrutica-tracked sovereign AI program for this country yet). See actor profile →
Touches Recursion Pharmaceuticals (chain hop 1) via a private-market fund. Fund commitment disclosed (amount held under license) (2018-05-10).
GIC Private
GIC is associated with Singapore’s Singapore: National AI Strategy 2.0 / AISG / NSCC Sovereign Compute. See actor profile →
Touches Recursion Pharmaceuticals (chain hop 1) via a private-market fund. Commitment dollar value not disclosed (2001-12-31).
The walk for Recursion BioHive-2starts at the operator org id (or owner org id when no operator is recorded) and climbs upward through the unified affiliate graph, normalized to trace child-to-parent relationships. At each hop, the highest-authority parent edge wins (priority ordering: SEC EDGAR / 10-K / LEI registry > licensed corporate-ownership database > licensed supply-chain database > BIS / Federal Register > licensed affiliate graph). Confidence and recency break ties.
The walk terminates on (a) a node with a public-filing-grade ancestor edge — a SEC filer, an LEI-registered listed entity, or a 10-K-disclosed parent — (b) a government entity, (c) a 10-hop limit, or (d) a detected cycle. When termination is not at a public filer or government, the panel labels the chain's end-state as opaque beyond that point. Opacity is reported, never implied.
Per-source confidence (licensed corporate-ownership database): HIGH for Parent / Subsidiary edges; MEDIUM for JV and AFFILIATE edges. Known limitations: (1) shell companies with undisclosed principals terminate the public-record walk; (2) recent transactions reach the panel after the database's weekly refresh; (3) cross-jurisdiction private holding structures may carry intermediate hops that are not in any ingested source. Each row carries an edge-level as of date so freshness is auditable per hop.
Two further caveats are inherent to how the walker and the underlying data compose. The walker selects a single highest-authority parent per hop, so JV or multi-parent ownership structures collapse to one displayed path; alternate parents exist in the ingested sources but are not surfaced on this card. And some licensed-database edges encode parent-of relations against entity-resolved stub IDs whose display name reflects a sub-entity (a business unit, an acquired-then-renamed line) rather than the canonical parent — when a chain reads structurally surprising, the per-row source citation is the authoritative reference, not the chain's narrative shape.
Computed at: 2026-06-12. Walk depth observed: 1 hop. Sources combined: Scrutica facility record + licensed corporate-ownership database + SEC CIK cross-reference + LEI registry + (where applicable) licensed supply-chain database + Federal Register designation closures. The licensed databases are held under subscription and not redistributed; per-hop labels name no vendor.